Skip to content
Screener

Astera Labs, Inc. ALAB Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number at other companies

Dynatrace logo
DynatraceDT
$1.64M-15.4%
1stdibs.com, Inc. logo
1stdibs.com, Inc.DIBS
$2.39M-28.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$3.87M+15.5%
Astera Labs, Inc. logo
Astera Labs, Inc.ALAB
$1.69M
Medline, Inc. logo
Medline, Inc.MDLN
$3.55M
Remitly Global, Inc. logo
Remitly Global, Inc.RELY
$4.24M-38.2%

Other financials

Income statement

See full
Revenue$392.4M+104%
Gross profit$287.6M+97.6%
Operating income$89.2M+124%
Net income$153.1M+199%
EPS (diluted)$0.83+186%

Balance sheet

See full
Cash & equivalents$111.5M-31.8%
Total debt$44.4M+37.5%
Total equity$1.7B+51.9%
Total assets$1.9B+51.9%

Cash flow

See full
Operating cash flow$87.7M-35.2%
CapEx$20.5M+912%
Free cash flow$67.2M-49.6%

Valuation

See full
Market cap$55.03B+84.7%
Enterprise value$54.97B+85.3%
P/E149×
P/S45.8×-3.4×

Profitability

See full
Gross margin75.1%-0.4pp
Operating margin22.8%+15.8pp
Net margin30.7%
FCF margin23%-11.7pp

Returns & leverage

See full
Return on equity25.8%
Debt / equity0.0×
Current ratio10.1×-1.0×

Where this comes from

Reported directly by Astera Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.

The source filing: Astera Labs, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001736297-26-000035
Line itemNumber of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
Outstanding as of December 31, 20252,721$0.865.5$450,336
Exercised(1,028)0.81
Outstanding as of June 30, 20261,693$0.895.0$816,380
Vested and expected to vest as of June 30, 20261,693$0.895.0$816,380
Exercisable as of June 30, 20261,668$0.905.0$804,240

ITEM 1. Financial Statements (Unaudited)

FAQ

What is Astera Labs, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number?
Astera Labs, Inc. (ALAB) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number of $1.69M in Q2 2026.
What does share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number mean?
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Ask your AI about Astera Labs, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude